288 related articles for article (PubMed ID: 14675037)
1. Treatment with anti-TGF-beta antibody ameliorates chronic progressive nephritis by inhibiting Smad/TGF-beta signaling.
Fukasawa H; Yamamoto T; Suzuki H; Togawa A; Ohashi N; Fujigaki Y; Uchida C; Aoki M; Hosono M; Kitagawa M; Hishida A
Kidney Int; 2004 Jan; 65(1):63-74. PubMed ID: 14675037
[TBL] [Abstract][Full Text] [Related]
2. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
Poncelet AC; de Caestecker MP; Schnaper HW
Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitin-dependent degradation of Smad2 is increased in the glomeruli of rats with anti-thymocyte serum nephritis.
Togawa A; Yamamoto T; Suzuki H; Fukasawa H; Ohashi N; Fujigaki Y; Kitagawa K; Hattori T; Kitagawa M; Hishida A
Am J Pathol; 2003 Oct; 163(4):1645-52. PubMed ID: 14507671
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of PAI-1 is mediated through TGF-beta/Smad pathway in transplant arteriopathy.
Dong C; Zhu S; Wang T; Yoon W; Goldschmidt-Clermont PJ
J Heart Lung Transplant; 2002 Sep; 21(9):999-1008. PubMed ID: 12231371
[TBL] [Abstract][Full Text] [Related]
5. Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse.
Hong SW; Isono M; Chen S; Iglesias-De La Cruz MC; Han DC; Ziyadeh FN
Am J Pathol; 2001 May; 158(5):1653-63. PubMed ID: 11337363
[TBL] [Abstract][Full Text] [Related]
6. Effects of Chinese traditional compound, JinSanE, on expression of TGF-beta1 and TGF-beta1 type II receptor mRNA, Smad3 and Smad7 on experimental hepatic fibrosis in vivo.
Song SL; Gong ZJ; Zhang QR; Huang TX
World J Gastroenterol; 2005 Apr; 11(15):2269-76. PubMed ID: 15818738
[TBL] [Abstract][Full Text] [Related]
7. Oxidized LDL activates PAI-1 transcription through autocrine activation of TGF-beta signaling in mesangial cells.
Song CY; Kim BC; Hong HK; Lee HS
Kidney Int; 2005 May; 67(5):1743-52. PubMed ID: 15840021
[TBL] [Abstract][Full Text] [Related]
8. Curcumin blocks multiple sites of the TGF-beta signaling cascade in renal cells.
Gaedeke J; Noble NA; Border WA
Kidney Int; 2004 Jul; 66(1):112-20. PubMed ID: 15200418
[TBL] [Abstract][Full Text] [Related]
9. Smad-3 and Smad-7 expression following anti-transforming growth factor beta 1 (TGFbeta1)-treatment in irradiated rat tissue.
Schultze-Mosgau S; Blaese MA; Grabenbauer G; Wehrhan F; Kopp J; Amann K; Rodemann HP; Rödel F
Radiother Oncol; 2004 Mar; 70(3):249-59. PubMed ID: 15064009
[TBL] [Abstract][Full Text] [Related]
10. Role of TGF-beta signaling in extracellular matrix production under high glucose conditions.
Li JH; Huang XR; Zhu HJ; Johnson R; Lan HY
Kidney Int; 2003 Jun; 63(6):2010-9. PubMed ID: 12753288
[TBL] [Abstract][Full Text] [Related]
11. Glycated albumin activates PAI-1 transcription through Smad DNA binding sites in mesangial cells.
Lee HS; Moon KC; Song CY; Kim BC; Wang S; Hong HK
Am J Physiol Renal Physiol; 2004 Oct; 287(4):F665-72. PubMed ID: 15198928
[TBL] [Abstract][Full Text] [Related]
12. N-Acetyl-seryl-aspartyl-lysyl-proline inhibits TGF-beta-mediated plasminogen activator inhibitor-1 expression via inhibition of Smad pathway in human mesangial cells.
Kanasaki K; Koya D; Sugimoto T; Isono M; Kashiwagi A; Haneda M
J Am Soc Nephrol; 2003 Apr; 14(4):863-72. PubMed ID: 12660320
[TBL] [Abstract][Full Text] [Related]
13. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
[TBL] [Abstract][Full Text] [Related]
14. TGF-beta induces proangiogenic and antiangiogenic factors via parallel but distinct Smad pathways.
Nakagawa T; Li JH; Garcia G; Mu W; Piek E; Böttinger EP; Chen Y; Zhu HJ; Kang DH; Schreiner GF; Lan HY; Johnson RJ
Kidney Int; 2004 Aug; 66(2):605-13. PubMed ID: 15253713
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of TGF-beta signal in hepatic stellate cells between acute and chronic rat liver injury.
Tahashi Y; Matsuzaki K; Date M; Yoshida K; Furukawa F; Sugano Y; Matsushita M; Himeno Y; Inagaki Y; Inoue K
Hepatology; 2002 Jan; 35(1):49-61. PubMed ID: 11786959
[TBL] [Abstract][Full Text] [Related]
16. The effects of platelet-derived growth factor antagonism in experimental glomerulonephritis are independent of the transforming growth factor-beta system.
Ostendorf T; Kunter U; van Roeyen C; Dooley S; Janjic N; Ruckman J; Eitner F; Floege J
J Am Soc Nephrol; 2002 Mar; 13(3):658-667. PubMed ID: 11856769
[TBL] [Abstract][Full Text] [Related]
17. Activation of the TGF-beta/Smad signaling pathway in focal segmental glomerulosclerosis.
Kim JH; Kim BK; Moon KC; Hong HK; Lee HS
Kidney Int; 2003 Nov; 64(5):1715-21. PubMed ID: 14531804
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta activated Smad signalling leads to a Smad3-mediated down-regulation of DSPP in an odontoblast cell line.
He WX; Niu ZY; Zhao SL; Jin WL; Gao J; Smith AJ
Arch Oral Biol; 2004 Nov; 49(11):911-8. PubMed ID: 15353247
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: the role of Smad3.
Yang F; Chung AC; Huang XR; Lan HY
Hypertension; 2009 Oct; 54(4):877-84. PubMed ID: 19667256
[TBL] [Abstract][Full Text] [Related]
20. The phosphatidylinositol 3-kinase/Akt pathway enhances Smad3-stimulated mesangial cell collagen I expression in response to transforming growth factor-beta1.
Runyan CE; Schnaper HW; Poncelet AC
J Biol Chem; 2004 Jan; 279(4):2632-9. PubMed ID: 14610066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
